Increased fatty acid synthase is a therapeutic target in mesothelioma

Clinical Cancer Research

Volumn 7, Issue 1, 2001, Pages 153-157

  Gabrielson, Edward W ^a   Pinn, Michael L ^a   Testa, Joseph R ^b   Kuhajda, Francis P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; ENZYME INHIBITOR C75; FATTY ACID; FATTY ACID SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; XENOGRAFT;

4-BUTYROLACTONE; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTINEOPLASTIC AGENTS; CERULENIN; DISEASE MODELS, ANIMAL; FATTY ACID SYNTHETASE COMPLEX; HUMANS; IMMUNOENZYME TECHNIQUES; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, MESOTHELIAL; PARAFFIN EMBEDDING; PROGNOSIS; TUMOR CELLS, CULTURED;

EID: 0035133059     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Malignant mesothelioma of the pleural space
2. Advances in the treatment of malignant pleural mesothelioma
3. Pleural mesothelioma: Clinical features and therapeutic implications
4. Survival of asbestos insulation workers with mesothelioma
5. Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology
6. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts
7. Increase fatty acid synthase as a therapeutic target in androgen independent prostate cancer progression
8. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients
9. Fatty acid synthase expression in endometrial carcinoma: Correlation with cell proliferation and hormone receptors
10. Synthesis and anti-tumor activity of a novel inhibitor of fatty acid synthase
11. Characterization of a human malignant mesothelioma cell line (H-MESO-1): A biphasic solid and ascitic tumor model
12. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer
13. Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 expression in hyperplastic parathyroids
14. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer
15. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia
16. A model study on the mechanism of fatty acid synthase inhibition by antibiotic cerulenin
17. Binding site of cerulenin in fatty acid synthetase
18. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells
19. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines
20. Changes in the size and composition of intracellular pools of nonesterified coenzyme A and coenzyme A thioesters in aerobic and facultatively anaerobic bacteria
21. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
22. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase
23. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis
24. Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2